Create account

Coverage dated November 8, 2026

Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials

Headline from MedicalXpress

For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult. In two Northwestern University–led Phase III clinical trials involving more than 1,000 participants combined, those…

MedicalXpress's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

2 articles, oldest first.

  1. New Atlas

    Knee osteoarthritis pain relief – and massive weight loss – from new GLP-1 (opens New Atlas)

    Published

    New Atlas's feed description

    Two Phase 3 clinical trials that involved more than 1,000 adults have significantly strengthened the case for Eli Lilly's experimental GLP-1-based drug retatrutide to gain FDA approval for both weight loss and relief from knee osteoarthritis (OA).

  2. MedicalXpress

    Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials (opens MedicalXpress)

    Published

    MedicalXpress's feed description

    For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult. In two Northwestern University–led Phase III clinical trials involving more than 1,000 participants combined, those…

Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials | Since Then